Suppr超能文献

凝血酶-血小板反应蛋白复合物形成的动力学:一种77 kDa中间体的参与

Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate.

作者信息

Browne P C, Miller J J, Detwiler T C

机构信息

Department of Biochemistry, State University of New York Health Science Center, Brooklyn 11203.

出版信息

Arch Biochem Biophys. 1988 Sep;265(2):534-8. doi: 10.1016/0003-9861(88)90158-0.

Abstract

Thrombin forms sodium dodecyl sulfate stable complexes of 77 and greater than 450 kDa with proteins secreted by activated platelets. The kinetics of formation of these complexes were investigated by addition of 125I-thrombin to the supernatant solution of A23187-activated platelets. Complexes were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis either with or without reduction of disulfide bonds. When analyzed on nonreduced gels, the 77-kDa complex reached a maximum at about 3 min and then declined as the greater than 450-kDa complex increased. On reduced gels (on which there was no greater than 450-kDa complex) the 77-kDa complex approached the level of the greater than 450-kDa complex on nonreduced gels. The half-time of formation was less than 1 min for the 77-kDa complex and about 15 min for the greater than 450-kDa complex. These time courses suggested that the 77-kDa complex was incorporated into the greater than 450-kDa complex as an essential precursor. Formation of complexes was inhibited by a competitive inhibitor or a noncompetitive inhibitor of thrombin, and the pH dependence of formation of both complexes was similar to the pH dependence for catalytic activity of thrombin. Ca2+ inhibited formation of the greater than 450-kDa complex but not of the 77-kDa complex. A model is presented in which thrombin and a secreted protein form a 77-kDa complex by a process that involves the active site of thrombin. The 77-kDa complex is then incorporated into a greater than 450-kDa complex by thiol-disulfide exchange with thrombospondin, a process that is inhibited by Ca2+. Thrombin in the greater than 450-kDa complex had no catalytic activity.

摘要

凝血酶与活化血小板分泌的蛋白质形成77 kDa和大于450 kDa的十二烷基硫酸钠稳定复合物。通过向A23187活化血小板的上清液中加入125I-凝血酶来研究这些复合物的形成动力学。复合物通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳进行分析,分析时可选择还原或不还原二硫键。在非还原凝胶上分析时,77 kDa复合物在约3分钟时达到最大值,然后随着大于450 kDa复合物的增加而下降。在还原凝胶上(不存在大于450 kDa复合物),77 kDa复合物接近非还原凝胶上大于450 kDa复合物的水平。77 kDa复合物的形成半衰期小于1分钟,大于450 kDa复合物的形成半衰期约为15分钟。这些时间进程表明,77 kDa复合物作为必需前体被整合到大于450 kDa复合物中。凝血酶的竞争性抑制剂或非竞争性抑制剂可抑制复合物的形成,两种复合物形成的pH依赖性与凝血酶催化活性的pH依赖性相似。Ca2+抑制大于450 kDa复合物的形成,但不抑制77 kDa复合物的形成。本文提出了一个模型,其中凝血酶和一种分泌蛋白通过涉及凝血酶活性位点的过程形成77 kDa复合物。然后,77 kDa复合物通过与血小板反应蛋白进行硫醇-二硫键交换而被整合到大于450 kDa复合物中,这一过程受到Ca2+的抑制。大于450 kDa复合物中的凝血酶没有催化活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验